Methods for characterizing compositions comprising peanut antigens
Methods for determining an in vitro release profile of peanut allergens in a sample are provided. Methods for determining one or more signatures of peanut allergens in a sample are provided.
1. A method for determining a signature of peanut allergens in an aqueous medium comprising:
digesting peanut allergens present in an aqueous medium to generate allergen digest products;
fragmenting the allergen digest products to generate peptide fragments; and
determining the signature of allergen digest products of peanut allergens of the aqueous medium by detecting the peptide fragments, wherein the signature comprises each of Ara h1, Ara h2, Ara h3, and Ara h6 digest products.
2. The method of claim 1 , wherein the aqueous medium is a dissolution medium, a release medium, or an analytical sample.
3. The method of claim 1 , wherein an amount of peanut allergens in the medium is less than about 2 μg/ml.
4. The method of claim 1 , further comprising a step of comparing the signature to a signature standard.
5. The method of claim 1 , wherein the allergen digest products are between about 4 amino acids and about 50 amino acids in length.
6. The method of claim 1 , wherein the signature comprises
Ara h1 allergen digest products having an amino acid sequence selected from the group consisting of SEQ ID NO:17, SEQ ID NO:70, SEQ ID NO:177, SEQ ID NO:155, SEQ ID NO:93 and SEQ ID NO:40.
7. The method of claim 1 , wherein the peanut allergens are digested with one or more proteases selected from the group consisting of trypsin, endoproteinase Lys-C and endoproteinase Arg-C.
8. The method of claim 1 , wherein the aqueous medium further comprises an internal standard.
9. The method of claim 8 , wherein the internal standard comprises one or more heavy isotopes.
10. The method of claim 1 , wherein an amount of peanut allergens in the medium is less than about 1.5 μg/ml.
11. The method of claim 1 , wherein an amount of peanut allergens in the medium is less than about 1 μg/ml.
12. The method of claim 1 , wherein an amount of peanut allergens in the medium is less than about 0.5 μg/ml.
13. The method of claim 1 , wherein fragmenting the allergen digest products and determining the signature are performed by a method selected from the group consisting of one or any combination of LC-MS, LC-MS-MS, nano-LC-MS-MS, and nanoHPLC-MS-MS.
14. The method of claim 1 , wherein the allergen digest products are between about 6 amino acids and about 30 amino acids in length.
15. The method of claim 1 , wherein the allergen digest products are between about 15 amino acids and about 20 amino acids in length.
16. The method of claim 1 , wherein the signature comprises allergen digest products from Ara h1, Ara h2, Ara h3 and Ara h6, having amino acid sequences selected from the group consisting of SEQ ID NO:17, SEQ ID NO:70, SEQ ID NO:177, SEQ ID NO:197, SEQ ID NO:198, SEQ ID NO:199, SEQ ID NO:200, SEQ ID NO:201, SEQ ID NO:236 and SEQ ID NO:237.
17. The method of claim 1 , wherein the signature comprises digest products that do not contain missed proteolytic cleavage sites.
18. A method for determining an in vitro release profile of peanut allergens from a substrate into an aqueous medium comprising:
obtaining a sample from the aqueous medium at each of a plurality of time points;
digesting the peanut allergens present in the samples to generate allergen digest products;
fragmenting the allergen digest products to generate peptide fragments; and
detecting the peptide fragments for at least two of the plurality of time points to identify the allergen digest products, thereby determining the in vitro release profile of the peanut allergens in the aqueous medium, wherein the release profile comprises each of Ara h1, Ara h2, Ara h3, and Ara h6 digest products.
19. The method of claim 18 , wherein the aqueous medium is a dissolution medium, a release medium, or an analytical sample.
20. The method of claim 18 , wherein an amount of peanut allergens in the medium is less than about 2 μg/ml.
21. The method of claim 18 , wherein the allergen digest products are between about 4 amino acids and about 50 amino acids in length.
22. The method of claim 18 , wherein the fragmenting the allergen digest products and detecting the peptide fragments are performed by a method selected from the group consisting of one or a combination of Liquid Chromatography-tandem Mass Spectroscopy (LC-MS-MS), nanoLC-MS-MS, and nano High Performance Liquid Chromatography-tandem Mass Spectroscopy (nanoHPLC-MS-MS).
23. The method of claim 18 , wherein the in vitro release profile comprises
Ara h1 allergen digest products having amino acid sequences selected from the group consisting of SEQ ID NO:17, SEQ ID NO:70, SEQ ID NO:177, SEQ ID NO:155, SEQ ID NO:93 and SEQ ID NO:40.
24. The method of claim 18 , wherein the peanut allergens are digested with one or more proteases selected from the group consisting of trypsin, endoproteinase Lys-C and endoproteinase Arg-C.
25. The method of claim 18 , wherein the aqueous medium further comprises an internal standard.
26. The method of claim 25 , wherein the internal standard comprises one or more heavy isotopes.
27. The method of claim 18 , wherein the substrate comprises one or both of nanoparticles and microparticles.
28. The method of claim 18 , wherein the release profile is obtained over a three-hour period of time.
29. The method of claim 18 , wherein an amount of peanut allergens in the medium is less than about 1.5 μg/ml.
30. The method of claim 18 , wherein an amount of peanut allergens in the medium is less than about 1 μg/ml.
31. The method of claim 18 , wherein an amount of peanut allergens in the medium is less than about 0.5 μg/ml.
32. The method of claim 18 , wherein the allergen digest products are between about 6 amino acids and about 30 amino acids in length.
33. The method of claim 18 , wherein the allergen digest products are between about 15 amino acids and about 20 amino acids in length.
34. The method of claim 18 , wherein the in vitro release profile comprises-allergen digest products from Ara h1, Ara h2, Ara h3 and Ara h6, selected from the group consisting of SEQ ID NO:17, SEQ ID NO:70, SEQ ID NO:177, SEQ ID NO:197, SEQ ID NO:198, SEQ ID NO:199, SEQ ID NO:200, SEQ ID NO:201, SEQ ID NO:236 and SEQ ID NO:237.
35. The method of claim 18 , wherein the in vitro release profile comprises-allergen digest products that do not contain missed proteolytic cleavage sites.
36. The method of claim 18 , wherein the release profile is obtained over a six-hour period of time.
37. The method of claim 18 , wherein the release profile is obtained over a twelve-hour period of time.
38. The method of claim 18 , wherein the release profile is obtained over a twenty-four-hour period of time.